Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients

Mapuskar, KA; Martinez, GV; Pulliam, CF; Petronek, MS; Steinbach, EJ; Mongo, V; Furqan, M; Jetton, JG; Saunders, DP; Pearce, A; Davidson, S; Pitre, L; Dunlap, NE; Fairbanks, R; Lee, CM; Mott, SL; Bodeker, KL; Cl, H; Buatti, JM; Anderson, CM; Beardsley, RA; Holmlund, JT; Zepeda-Orozco, D; Spitz, DR; Allen, BG

Spitz, DR; Allen, BG (通讯作者)，Univ Iowa Hosp & Clin, Div Free Rad & Radiat Biol, Dept Radiat Oncol, Iowa City, IA 52242 USA.

REDOX BIOLOGY, 2023; 60 ():

Abstract

Head and neck squamous cell carcinoma (HNSCC) patients treated with high-dose cisplatin concurrently with radiotherapy (hdCis-RT) commonly suffer kidn......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索